Innovating Works
Immune-senescence: Dual targeting of senescence and tumor immunity for cancer therapy FONDAZIONE PER LISTITUTO ONCOLOGICO DI RICERCA IOR tramitó un H2020: ERC-2015-CoG We have previously demonstrated that cellular senescence opposes tumorigenesis thereby opening up new potential opportunities for cancer tre...
2016-06-23 - 2021-06-30 | Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.